Join
Live feed
·
INSIDERFilingvia Quantisnow
Reviva Pharmaceuticals Holdings Inc. logo

SEC Form 4: Patel Purav bought $14,070 worth of shares (3,000 units at $4.69), increasing direct ownership by 7% to 43,547 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RVPH (Reviva Pharmaceuticals Holdings Inc.) and more on Quantisnow.